Parapneumonic effusion and empyema
Parapneumonic effusion and empyema
复制标题
DOI：
10.1183/09031936.97.10051150
复制
发表时间：
1997-05-01
影响因子：
24.3
通讯作者：
Light, RW
中科院分区：
文献类型：
--
作者：
Hamm, H;Light, RW
肺旁积液约占所有胸腔积液的三分之一。大约40%的肺炎患者并发积液，这与发病率和死亡率增加有关。为了对个别患者选择最合适的治疗方法，应将积液分为渗出性、纤维化脓性或组织性阶段，并收集所有必要的信息，以确定积液的病程是简单还是复杂。肺旁积液的侵袭性和病程有相当大的差异，因此，适当的治疗范围可以从保守的方法在无并发症的积液到积极的手术干预在晚期多房性脓胸。这篇综述讨论了目前的诊断和治疗方案，并提供了治疗不同阶段的肺旁积液和脓胸的指南。
Parapneumonic effusions account for about one third of all pleural effusions. Approximately 40% of patients with pneumonia develop a concomitant effusion, which is associated with an increased morbidity and mortality.In order to select the most appropriate therapy for the individual patient, the effusion should be categorized as being in the exudative, fibropurulent or organizational stage, and all necessary information should be compiled to decide whether the effusion is likely to take an uncomplicated or a complicated course, There is a considerable variation in the aggressiveness and course of parapneumonic effusions, and, therefore, the spectrum of the appropriate therapy may vary from a conservative approach in uncomplicated effusions to aggressive surgical intervention in advanced multiloculated empyemas.This review discusses current diagnostic and therapeutic options and offers guidelines for treating the various stages of parapneumonic effusions and empyemas.